Literature DB >> 1445279

First determination of the secondary structure of purified factor VIII light chain.

N Bihoreau1, M P Fontaine-Aupart, A Lehegarat, M Desmadril, J M Yon.   

Abstract

The first analysis of the secondary structure of human factor VIII light chain was performed by c.d. spectroscopy. The purification process described in this paper allowed us to obtain the large amounts of purified factor VIII light chains required for c.d. experiments. Since this 80 kDa protein is non-covalently associated with a heavy chain to form the active molecule, isolated factor VIII light chains were obtained after immunoadsorption and dissociation of the immobilized active complexes by EDTA. Furthermore, factor VIII light chains were discriminated from the residual active complexes and the free heavy chains by a final ion-exchange-chromatography step. This f.p.l.c. analysis showed that factor VIII light chains were less electronegative than the active complexes. The results of conformational analysis by c.d. show that the protein possesses a high degree of regular secondary structure (58%) with approx. 22% of alpha-helix and 36% of beta-strand structures. The protein was completely unfolded by 3 M-guanidine hydrochloride. The results obtained from the analysis of c.d. spectra were compared with those predicted from three different statistical methods based on amino-acid sequence. The secondary structure information obtained from these methods was in good agreement with the c.d. results. These results were comparable with the secondary structure prediction of ceruloplasmin, a protein known to show sequence identity to factor VIII.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445279      PMCID: PMC1132076          DOI: 10.1042/bj2880035

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.

Authors:  N Bihoreau; P Paolantonacci; C Bardelle; M P Fontaine-Aupart; S Krishnan; J Yon; J L Romet-Lemonne
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

2.  Circular dichroic analysis of protein conformation: inclusion of the beta-turns.

Authors:  C T Chang; C S Wu; J T Yang
Journal:  Anal Biochem       Date:  1978-11       Impact factor: 3.365

3.  Structural patterns in globular proteins.

Authors:  M Levitt; C Chothia
Journal:  Nature       Date:  1976-06-17       Impact factor: 49.962

4.  Further developments of protein secondary structure prediction using information theory. New parameters and consideration of residue pairs.

Authors:  J F Gibrat; J Garnier; B Robson
Journal:  J Mol Biol       Date:  1987-12-05       Impact factor: 5.469

Review 5.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

6.  Computed circular dichroism spectra for the evaluation of protein conformation.

Authors:  N Greenfield; G D Fasman
Journal:  Biochemistry       Date:  1969-10       Impact factor: 3.162

7.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

9.  Structural model of human ceruloplasmin based on internal triplication, hydrophilic/hydrophobic character, and secondary structure of domains.

Authors:  T L Ortel; N Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  A circular dichroism study of undegraded human ceruloplasmin.

Authors:  M Noyer; F W Putnam
Journal:  Biochemistry       Date:  1981-06-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.